A Study on PELGE Nanoparticles as Controlled Drug Delivery Systems for Intravenous


Article Preview

The objective of this study was to evaluate the in vivo characteristics of poly (ethylene glycol)-poly (lacticacid-co-glycolicacid)-poly (ethylene- glycol) (PELGE) copolymers as drug carriers. In order to test this circulation time, mitoxantrone (DHAQ) was used as a model drug in this study. DHAQ nanoparticles (DHAQ-NP) were prepared, subsequently the DHAQ-NP were evaluated by measuring the drug concentration in plasma after intravenous administration via the tail vein of mice. The circulation time of the DHAQ-NP were tested. The results showed prolonged mitoxantrone (DHAQ) residence in systemic blood circulation.



Key Engineering Materials (Volumes 288-289)

Edited by:

Xingdong Zhang, Junzo Tanaka, Yaoting Yu and Yasuhiko Tabata




Y. R. Duan et al., "A Study on PELGE Nanoparticles as Controlled Drug Delivery Systems for Intravenous", Key Engineering Materials, Vols. 288-289, pp. 163-166, 2005

Online since:

June 2005




[1] Li S. M, Vert M, in degradable polymers: principles and applications, G. Scott and D. Gilead, Eds., Chapman &Hall, London, (1995), pp.43-87.

[2] Liu, W.S. Huang, Y. Zhang, Z.R. Synthesis and Characterization of the Tumor Targeting Mitoxantrone -Insulin Conjugate. Archives of Pharmacal Research. 26 (2003), 892-897.

DOI: https://doi.org/10.1007/bf02980195

[3] Avgoustakis, K. Beletsi, A. Ithakissios, D.S. Journal of Controlled Release. 79 (2002), 123-135.